Related Experiment Video
Updated: May 2, 2026
11:34
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
13.2K
Determining anti-betanodavirus compounds through a GF-1 cell-based screening platform
1Institute of Fisheries Science, College of Life Science, National Taiwan University, Taipei, Taiwan.
Antiviral Research
|March 4, 2014
Summary
Researchers developed a new cell viability assay to find drugs against betanodavirus, a pathogen causing significant aquaculture losses. They identified promising compounds, including proadifen hydrochloride, that inhibit viral RNA amplification.
Area of Science:
- Aquaculture
- Virology
- Drug Discovery
Background:
- Betanodavirus causes substantial economic losses in aquaculture.
- Existing treatments lack efficacy against early-stage fish larvae infections.
Purpose of the Study:
- To develop a cell viability-based screening assay for identifying anti-betanodavirus agents.
- To discover novel compounds effective against betanodavirus.
Main Methods:
- Optimized a GF-1 cell viability assay.
- Screened a library of 2000 small molecule compounds.
- Validated hit compounds using EC50 and CC50 values.
Main Results:
- Developed a robust assay (Z' factor 0.7-0.94).
- Identified 43 compounds with ⩾55% virus inhibition.
- Proadifen hydrochloride showed potent antiviral activity (EC50=6.48μM) and inhibited viral RNA amplification by 99.68%.
Conclusions:
- The novel assay facilitates the discovery of anti-betanodavirus drugs.
- Proadifen hydrochloride is a potential candidate for treating betanodavirus infections.
- Discovery of neurotransmitter agents suggests new research avenues for betanodavirus infection mechanisms.
